Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 3Upper Gastrointestinal Tumours 1Solid Tumor 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Neutropenia 1Colonic Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

pegfilgrastim 3Vancomycin 2Teicoplanin 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Cefepime 2posaconazole 1pegylated granulocyte colony-stimulating factor 1Vascular Access Devices 1Ofloxacin 1Metronidazole 1Leucovorin 1Lenograstim 1Irinotecan 1Fluorouracil 1Cilastatin, Imipenem Drug Combination 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neutropenia × Irinotecan × Clear all
NCT01271582 2019-01-29

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Asan Medical Center

Phase 4 Unknown
1,500 enrolled
Gastrointestinal

Neutropenia, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡